Chemical modification of small molecules is a key step for the development of pharmaceuticals. S‐adenosyl‐l‐methionine (SAM) analogues are used by methyltransferases (MTs) to transfer alkyl, allyl and benzyl moieties chemo‐, stereo‐ and regioselectively onto nucleophilic substrates, enabling an enzymatic way for specific derivatisation of a wide range of molecules. l‐Methionine analogues are required for the synthesis of SAM analogues. Most of these are not commercially available. In nature, O‐acetyl‐l‐homoserine sulfhydrolases (OAHS) catalyse the synthesis of l‐methionine from O‐acetyl‐l‐homoserine or l‐homocysteine, and methyl mercaptan. Here, we investigated the substrate scope of ScOAHS from Saccharomyces cerevisiae for the production of l‐methionine analogues from l‐homocysteine and organic thiols. The promiscuous enzyme was used to synthesise nine different l‐methionine analogues with modifications on the thioether residue up to a conversion of 75 %. ScOAHS was combined with an established MT dependent three‐enzyme alkylation cascade, allowing transfer of in total seven moieties onto two MT substrates. For ethylation, conversion was nearly doubled with the new four‐enzyme cascade, indicating a beneficial effect of the in situ production of l‐methionine analogues with ScOAHS.